NIH-funded research R21 grant

Understanding how poxviruses adapt to evade the immune system

Official title: APOBEC3-driven host mechanism promotes poxvirus diversification to overcome host immune restriction

Funded at Univ of Arkansas for Med Scis · NIH-11127241 · Data updated 2026-11-12

This study is looking at how a special enzyme in our bodies affects the way poxviruses, like monkeypox, change and adapt, which could help us find better ways to treat and prevent these infections in the future.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of Arkansas for Med Scis
NIH-funded
Lab location1 site (Little Rock, United States)
Project startMay 1, 2025
Project endApril 30, 2027
Funding year2025
Award (this year)$221,105
NIH project number1R21AI191013-01
Project IDNIH-11127241 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who may be at risk for poxvirus infections, such as those in close contact with infected individuals or in areas experiencing outbreaks.

Less likely to help

Patients who are not at risk for poxvirus infections or those who have already been vaccinated against these viruses may not receive direct benefits from this research.

What this research studies

This research investigates how the APOBEC3 enzyme in the human body influences the mutation and evolution of poxviruses, such as monkeypox. By analyzing viral genomes, the researchers aim to uncover the mechanisms that allow these viruses to change and potentially evade the immune response. The study focuses on understanding specific mutations that occur in the viral DNA, which could help predict how these viruses might evolve in the future. This knowledge could be crucial for developing better treatments and preventive measures against poxvirus infections.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for predicting and controlling poxvirus outbreaks, ultimately enhancing public health responses.

How similar studies have gone: Previous research has shown that understanding viral mutation mechanisms can lead to significant advancements in managing viral infections, indicating that this approach has potential for success.

Where this research is happening

  • Univ of Arkansas for Med Scis
    Little Rock, United States
    Active

Researchers

  • Principal investigator: Liu, Jia — Univ of Arkansas for Med Scis
  • Study coordinator: Liu, Jia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.